Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Agenus
Jun 12, 2024, 03:29 |
Blog
Agenus is participating in the Goldman Sachs 45th Annual Global Healthcare Conference
Agenus shared on LinkedIn: “Tomorrow, Agenus is participating in the Goldman Sachs 45th Annual Global Healthcare…
Jun 10, 2024, 16:17 |
Blog
Steven O’Day will be presenting an update on botensilimab programs at Nature Conferences’s event - Agenus
Quoting Agenus on X: "Tomorrow, Dr. Steven O’Day will be speaking at Nature Conferences’ Cancer Immunotherapy…
Jun 7, 2024, 11:02 |
Career
Robin Taylor: Wonderful to have Eric Olson bringing his extensive Regulatory experience to Agenus
Robin Taylor, Chief Commercial Officer at Agenus, recently shared a post by Eric Olson, former…
Jun 4, 2024, 10:34 |
Blog
Congratulations to Dr. Pashtoon Kasi on receiving the Yvonne Award from OncoDaily - Agenus
Agenus shared on LinkedIn: "Congratulations to Dr. Pashtoon Kasi on receiving the Yvonne Award from OncoDaily…
Jun 4, 2024, 05:09 |
Insight
Join us in Chicago to discuss the future of immuno-oncology - Agenus
Agenus shared a post on LinkedIn: “Are you a physician attending ASCO24? Join us in…
May 31, 2024, 23:43 |
Blog
Dr. Benny Johnson shares his insights on the importance of innovative immunotherapy treatments - Agenus
Agenus shared a post on LinkedIn: "As Cancer Research Month nears a close, Dr. Benny Johnson shares…
May 30, 2024, 11:22 |
Societies
A new analysis of bot/bal in metastatic MSS colorectal cancer at ASCO24 - Agenus
Agenus recently shared a post on LinkedIn: "Agenus is headed to ASCO24 where Dr. Marwan…
May 23, 2024, 09:37 |
Blog
Agenus: We’re proud to share Dr. Joseph Grossman’s perspective of our investigational immunotherapy pipeline
Agenus shared a post on LinkedIn: "At Agenus, we aim to transform care for individuals living…
May 17, 2024, 11:18 |
Drugs
Agenus has been granted a Type B End-of-Phase 2 meeting from the U.S. FDA
Agenus shared on LinkedIn: “Today we announced that Agenus has been granted a Type B…
May 13, 2024, 07:25 |
Blog
Partnership between Ligand Pharmaceuticals and Agenus
Ligand Pharmaceuticals shared on their LinkedIn page: "We are excited to announce our latest royalty…
2
3
4
5
6
All:
117
Posts:
31 - 40
Why a Radiation Oncologist Isn’t Simply a Radiologist plus Medical Oncologist: Key Differences Explained
Dikembe Mutombo: In Memory of Basketball Icon Who Died at 58 Battling Brain Cancer
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 7
César Milstein - The Father of Modern Immunology
ESTRO: Everything You Need to Know About European Society for Radiotherapy and Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube